2014
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
Search citation statements
Paper Sections
Select...
954
272
148
135
Citation Types
31
1,252
3
30
Year Published
2000
2026
Publication Types
Select...
1,203
76
42
19
Relationship
31
1,309
Authors
Journals
Cited by 1,318 publications
(1,316 citation statements)
References 39 publications
31
1,252
3
30
“…A major strength of the present study is well defined cohort with detailed histopathological assessment due to Banff 2013 Criteria [11]. In our study, chronic AMR was diagnosed in 55% of the cohort and median transplant glomerulopathy scores were similar among groups.…”
Section: Discussioncontrasting
confidence: 95%
“…A major strength of the present study is well defined cohort with detailed histopathological assessment due to Banff 2013 Criteria [11]. In our study, chronic AMR was diagnosed in 55% of the cohort and median transplant glomerulopathy scores were similar among groups.…”
Section: Discussioncontrasting
confidence: 95%
“…The rate of graft survival in the AMR− TMA group was significantly higher than in the AMR+ TMA group. Our data were in accordance with the study of Satoskar et al , who reported that most (55%) of the patients with de novo TMA in the renal allograft had evidence of AMR. AMR may play a causative or contributory role in the development of TMA in allografts ; typical TMA lesions frequently coexisted with the features of AMR , and the presence of TMA lesions raised the suspicion of an underlying AMR.…”
Section: Discussionsupporting
confidence: 93%
“…It was observed that TCMR was more frequent in all groups of transplanted patients with LD and for patients from G1 who received a kidney from a DD, but graft losses were more frequent in patients who experienced AMR transplanted with DF. These data are in agreement with other publications [21, 23, 34]. Graft loss was observed in patients from G3 who received a kidney from an LD, but no graft loss was demonstrated in immunotherapy patients from G3 and G4 who received a kidney from a DD.…”
Section: Discussionsupporting
confidence: 93%
